Hepatitis Delta: Increasing Awareness and Treatment Competencies - December 14, 2022 – May 3, 2023

A series of live educational session focused on disease risk factors, progression, screening, surveillance and prevention of Delta Hepatitis. One of the key audiences will be 'at risk and underserved populations. We will target HCP's in community clinics, VA medical centers, community hospitals and clinician training programs. We will focus on physicians, NP's, PA's, RN's and community health and social service workers.
When Dec 14, 2022 12:00 PM to
May 03, 2023 01:30 PM
Where Various Dates and Locations - See Below
Contact Name
Contact Phone (253) 432-4023
Add event to calendarvCal

  • This program is also available as a web-based self-study CME Enduring Material activity.
    Click Here for more information.

Target Audience
This activity is focused on the educational needs of physicians, advanced-practice clinicians and others who care for patients who have contracted or at-risk for developing viral hepatitis. They can be found in hospitals, academic medical centers, private practice and community-based health centers and clinics.

Program Agenda (Times May Vary)
12:00 – 12:05pm
Introduction to the seminar and the speaker

12:05 – 1:20pm                            

  • Discovery and natural history of the Delta Virus
  • Interaction and relationship with Hepatitis B infection
  • Prevalence and growth of HDV in the US and Worldwide
  • Modes of transmission and prevention approaches
  • Who and how to screen for Delta Hepatitis?  What are the current and emerging screening approaches, their benefits, and challenges?
  • Disease burden and the impact of HDV on morbidity and mortality
  • Current and emerging therapies for HDV – benefits and potential side effects
  • Reducing the incidence of HDV in special populations
  • Overcoming the barrier to reinfection
  • Analysis of real-world clinical cases relevant to each audience
  • Take-home lessons and Proactive next steps

1:20 – 1:30pm
Questions, Discussion, Wrap-up and Adjourn

Learning Objectives
Those who actively participate in this activity will be able to:
1. Articulate the key elements in the growth in incidence of Delta Hepatitis.
2. Explain how and why HBV infected individuals are at risk for HDV.
3. Discuss how HDV infection has spread throughout the world and what impact it is having on individuals in the United States.
4. Prepare your practice to screen patients and increase sensitivity to populations at risk.
5. Increase awareness of current and emerging therapies for Delta Hepatitis.
6. Evaluate the benefits and potential risk of HDV therapies.
7. Develop patient and staff education modules to reduce hepatitis outbreaks and improve awareness of prevention methods.
8. Translate the lessons of clinical cases to improve you diagnostic and treatment skills.
9. Drive down the frequency of viral hepatitis in your practice and in your community.

Registration Fees
There is no fee to attend this event but advance registration is requested to allow for event planning.

To Register
Click on a date and location below to register for a program

If online registration has closed you may still attend the event by registering as a walk-in the day of the program.

December 14, 2022 - McLean, VA
Venue: Virginia Association of Physician Assistants
Faculty: Kirti Shetty, MD: University of Maryland School of Medicine
View the Course Flyer

March 8, 2023 - Houston, TX
Venue: Maggiano’s Little Italy  2019 Post Oak Blvd
Hosted by Harris County Academy of Family Physicians
Faculty: Saira Khaderi, MD: Baylor University
View the Course Flyer

March 23, 2023 - Westminster, CA
Venue: Grand Garden Restaurant, 8894 Bolsa Avenue
Hosted by Vietnamese Physician’s Association
Faculty: Robert Gish, MD: Hepatitis B Foundation
View the Course Flyer

March, 28, 2023 - Miami, FL
Venue: University of Miami School of Medicine
Faculty:  Ira Jacobson, MD NYU Langone School of Medicine
View the Course Flyer

May 3, 2023 - Orlando, FL
Venue: Maggiano’s Little Italy – 9101 International Drive
Faculty: Carla Molliner, PA-C – University of Miami
View the Course Flyer

Joint Provider Statement
UofL CMEPD logoThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and SC Liver Research Consortium. The University of Louisville School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 Designation Statement
The University of Louisville School of Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses - This program has been approved by the Kentucky Board of Nursing for 1.8 continuing education credits through University of Louisville Hospital, provider number 4-0068-12-22-1298. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Completion criteria to obtain CE's: Attend entire session and complete the evaluation.

Jointly Provided By

Disclosure of Ineligible Company Support
This activity has been supported by an educational grants from Gilead and Eiger.

Accreditation Disclosure
As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its accredited educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined. If any relevant financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were peer-reviewed and determined to be without ineligible company bias, were considered fair and balanced in terms of therapeutic options, and presented evidence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.

Learner Consent Statement
Names or contact information of learners will not be shared with any ineligible company or its agents without the explicit consent of the individual learner.

CME Enduring Material Activity 
Welcome to On-line version of the Hepatitis Delta: Increasing Awareness and Treatment Competencies Syndrome Seminars. This Online CME Enduring Material is focused on disease risk factors, progression, screening, surveillance and prevention of Delta Hepatitis.

You will have to register and create a user profile before you are able to view the material.
Once you have finished viewing the material you can either close the presentation window or select the CME Publisher Portal window at the top of the screen to continue with your post-test, evaluation, and generation of your CME certificate.
CLICK HERE to go to the enduring material activity landing webpage.